Publication

Biallelic mutations in calcium release activated channel regulator 2A (CRACR2A) cause a primary immunodeficiency disorder

Graph Chat

Chat with Graph Search

Ask any question about EPFL courses, lectures, exercises, research, news, etc. or try the example questions below.

DISCLAIMER: The Graph Chatbot is not programmed to provide explicit or categorical answers to your questions. Rather, it transforms your questions into API requests that are distributed across the various IT services officially administered by EPFL. Its purpose is solely to collect and recommend relevant references to content that you can explore to help you answer your questions.

Biallelic mutations in calcium release activated channel regulator 2A (CRACR2A) cause a primary immunodeficiency disorder

Chat with Graph Search

Unlocking Hidden Potential: Exploring the Complexities of Signaling in Immune Cell Activation to Optimize CAR Therapy

Investigating the effect of inflammation on the progression of B-cell lymphoma dissemination in the sentinel lymph node

Exploring the interplay of molecular pattern and valency for selective interactions at the bio-interface

Rational Design of Chemically Controlled Antibodies and Protein Therapeutics

Development of a novel Chimeric Antigen Receptor (CAR) for its use in Natural Killer (NK) cells for cancer treatment and beyond

Direct In Vivo Activation of T Cells with Nanosized Immunofilaments Inhibits Tumor Growth and Metastasis

Acute TNF alpha levels predict cognitive impairment 6-9 months after COVID-19 infection

Interspecies interactions determine growth dynamics of biopolymer- degrading populations in microbial communities

Low temperature and mTOR inhibition favor stem cell maintenance in human keratinocyte cultures

Nanotechnology enabled modulation of T cell immunity for cancer treatment

Tracking spatiotemporal localisation and interactions of the innate immune sensor STING

Caspase-9-mediated cleavage of vimentin attenuates the aggressiveness of leukemic NB4 cells